Clinical trial
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
NCT02101385
Study timeline
Study start (actual)2014-04-03Date precision: day
Registry last updated2023-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Malignant Neoplasm of Breastunresolved
Breast Cancerunresolved
Interventions
Sponsors & collaborators
Bryan Schneider, MDlead sponsor
Hoosier Cancer Research Networkcollaborator
Vera Bradley Foundation for Breast Cancercollaborator
Walther Cancer Institutecollaborator
Indiana Universitycollaborator
Mapped research locations
IndianapolisIndiana, United States3BostonMassachusetts, United States1ChicagoIllinois, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1Washington D.C.District of Columbia, United States1Oklahoma CityOklahoma, United States1OmahaNebraska, United States1MilwaukeeWisconsin, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02101385 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.